|Videos|December 20, 2019
Management of HER2 Expression in Breast Cancer
Author(s)Sponsored Content
Ian E. Krop, MD, PhD, provides insight on HER2 expression in breast cancer, treatment for blocking HER2, and the management of newly diagnosed HER2+ metastatic breast cancer with T-DM1.
Advertisement
Ian E. Krop, MD, PhD, provides insight on HER2 expression in breast cancer, treatment for blocking HER2, and the management of newly diagnosed HER2+ metastatic breast cancer with T-DM1.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Chronic Myeloid Leukemia: From Diagnosis to Ongoing Management
2
Given Months to Live, She’s Now a Five-Year Glioblastoma Survivor
3
Tecvayli With Darzalex Could Be ‘Truly Transformative’ in Multiple Myeloma
4
First U.S. Patient Treated With Alveltamig for Small Cell Lung Cancer
5